Canada markets closed

BioLargo, Inc. (BLGO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3396+0.0251 (+7.99%)
At close: 03:59PM EDT

BioLargo, Inc.

14921 Chestnut Street
Westminster, CA 92683
United States
888 400 2863
https://www.biolargo.com

Sector(s)Basic Materials
IndustryChemicals
Full Time Employees31

Key Executives

NameTitlePayExercisedYear Born
Mr. Dennis P. CalvertChairman, President & CEO316.59kN/A1963
Mr. Joseph L. ProvenzanoExecutive VP of Operations, Corporate Secretary & Director223.57kN/A1969
Mr. Kenneth Reay CodeChief Science Officer & Director301.2kN/A1947
Mr. Alex EvansDirector of Corporate CommunicationsN/AN/AN/A
Mr. Steven V. Harrison IIPresident of Clyra Medical Technologies Inc30.24kN/A1959
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

Corporate Governance

BioLargo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.